Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Hijacking of the Fibrinolytic System By B-Cell Acute Lymphoblastic Leukaemia and Its Therapeutic Targeting

Valentina Minciacchi, Christina Karantanou, Costanza Zanetti, Rahul Kumar, Theresa Krack, Nathalie Thomasberger, Pablo Llavona, Sylvia Hartmann, Veronique Maguer-Satta, Sylvain Lefort, Mateusz Putyrski, Andreas Ernst, Eshwar Meduri, Brian Huntly, Wolfram Ruf, Daniela S. Krause

Blood (2023) 142 (Supplement 1): 2781.

https://doi.org/10.1182/blood-2023-178811

Published: 2023

Journal Articles

Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies

Dennis A. Eichenauer, Ina Bühnen, Christian Baues, Carsten Kobe, Helen Kaul, Richard Greil, Alden Moccia, Joseé M. Zijlstra, Bernd Hertenstein, Max S. Topp, Marianne Just, Bastian von Tresckow, Hans-Theodor Eich, Michael Fuchs, Markus Dietlein, Sylvia Hartmann, Andreas Engert, Peter Borchmann

Blood (2023) 142 (6): 553–560.

https://doi.org/10.1182/blood.2023019939

Published: 2023

Journal Articles

The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13

Blood (2021) 138 (19): 1870–1884.

https://doi.org/10.1182/blood.2021011557

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

Treatment of Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Subgroup Analysis of the Randomized German Hodgkin Study Group HD16 Study

Dennis A. Eichenauer, Ina Bühnen, Michael Fuchs, Helen Kaul, Carsten Kobe, Sylvia Hartmann, Christian Baues, Bastian von Tresckow, Peter Borchmann, Andreas Engert

Blood (2021) 138 (Supplement 1): 2439.

https://doi.org/10.1182/blood-2021-145427

Published: 2021

Journal Articles

LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

Blood (2021) 137 (23): 3251–3258.

https://doi.org/10.1182/blood.2020008835

Published: 2021

Includes: Supplemental data

Journal Articles

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Blood (2020) 135 (3): 181–190.

https://doi.org/10.1182/blood.2019000560

Published: 2020

Includes: Supplemental data

Journal Articles

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Blood (2019) 133 (15): 1664–1676.

https://doi.org/10.1182/blood-2018-09-872549

Published: 2019

Includes: Supplemental data

Journal Articles

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Blood (2018) 132 (26): 2744–2753.

https://doi.org/10.1182/blood-2018-03-836932

Published: 2018

Includes: Supplemental data

Journal Articles

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

Julia Richter, PhD, Andreas Hüttmann, MD, Jan Rekowski, MSc, Christine Schmitz, MD, Selina Gärtner, MS, BS, Claudia Ose, MSc, Andreas Rosenwald, Martin-Leo Hansmann, Sylvia Hartmann, MD, Peter Moeller, MD, Hans-Heinrich Wacker, MD, Alfred Feller, Christoph Thorns, MD, Stefan P. Müller, MD, Ulrich Duehrsen, MD, Wolfram Klapper, MD

Blood (2018) 132 (Supplement 1): 4188.

https://doi.org/10.1182/blood-2018-99-112815

Published: 2018

Journal Articles

Identification of Posttranvslationally Modified Neoantigens As Targets of B Cell Receptors of Burkitt Lymphoma

Lorenz Thurner, MD, Sylvia Hartmann, MD, Theresa Bock, Natalie Fadle, Maria Kemele, Evi Regitz, Moritz Bewarder, MD, Sigrun Smola, Thorsten Pfuhl, Jana Held, Rainer-Maria Bohle, Laurence de Leval, MD, Rabea Wagener, Reiner Siebert, PhD, Martin-Leo Hansmann, Stephan Stilgenbauer, MD PhD, Klaus Dieter Preuss, PhD, Michael Pfreundschuh, MD

Blood (2018) 132 (Supplement 1): 1588.

https://doi.org/10.1182/blood-2018-99-114209

Published: 2018

Journal Articles

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

Blood (2018) 132 (16): 1695–1702.

https://doi.org/10.1182/blood-2018-03-837252

Published: 2018

Includes: Supplemental data

Journal Articles

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network

Sietse M. Aukema, Eva Hoster, Andreas Rosenwald, Danielle Canoni, Marie-Hélène Delfau-Larue, Grzegorz Rymkiewicz, Christoph Thorns, Sylvia Hartmann, Hanneke Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfram Klapper

Blood (2018) 131 (4): 417–420.

https://doi.org/10.1182/blood-2017-07-797019

Published: 2018

Includes: Supplemental data

Journal Articles

The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)

Johannes Hellmuth, MD, Abner Louissaint, MD PhD, Monika Szczepanowski, PhD, Sarah Häbe, MD, Alessandro Pastore, MD, Annette M. Staiger, PhD, Sylvia Hartmann, Robert Kridel, Matthew D. Ducar, MS, Peter Koch, MD, Martin Dreyling, MD PhD, Martin-Leo Hansmann, MD, German Ott, MD, Andreas Rosenwald, MD, Randy D. Gascoyne, MD, David M. Weinstock, MD, Wolfgang Hiddemann, MD PhD, Wolfram Klapper, MD, Oliver Weigert, MD

Blood (2017) 130 (Supplement 1): 2735.

https://doi.org/10.1182/blood.V130.Suppl_1.2735.2735

Published: 2017

Journal Articles

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Blood (2016) 128 (22): 151.

https://doi.org/10.1182/blood.V128.22.151.151

Published: 2016

Journal Articles

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Blood (2016) 128 (22): 4096.

https://doi.org/10.1182/blood.V128.22.4096.4096

Published: 2016

Journal Articles

LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)

Lorenz Thurner, MD, Sylvia Hartmann, Klaus-Dieter Preuss, PhD, Natalie Fadle, Maria Kemele, Evi Regitz, Christiane Pott, MD PhD, Rainer-Maria Bohle, Martin-Leo Hansmann, Michael Pfreundschuh, MD

Blood (2015) 126 (23): 2685.

https://doi.org/10.1182/blood.V126.23.2685.2685

Published: 2015

Journal Articles

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Eva Hoster, PhD, Andreas Rosenwald, MD, Francoise Berger, MD PhD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Michael Unterhalt, MD, Johanna C. Kluin-Nelemans, Olivier Hermine, MD PhD, Wolfgang Hiddemann, MD PhD, Martin H. Dreyling, Wolfram Klapper, MD

Blood (2014) 124 (21): 2977.

https://doi.org/10.1182/blood.V124.21.2977.2977

Published: 2014

Journal Articles

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Sylvia Hartmann, Dennis A. Eichenauer, Annette Plütschow, Anja Mottok, Roshanak Bob, Karoline Koch, Heinz-Wolfram Bernd, Sergio Cogliatti, Michael Hummel, Alfred C. Feller, German Ott, Peter Möller, Andreas Rosenwald, Harald Stein, Martin-Leo Hansmann, Andreas Engert, Wolfram Klapper

Blood (2013) 122 (26): 4246–4252.

https://doi.org/10.1182/blood-2013-07-515825

Published: 2013

Includes: Supplemental data

Journal Articles

The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL

Blood (2013) 122 (21): 4262.

https://doi.org/10.1182/blood.V122.21.4262.4262

Published: 2013

Journal Articles

Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.

Eva Hoster, Wolfram Klapper, Andreas Rosenwald, MD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Wolfgang Hiddemann, MD, PhD, Michael Unterhalt, Hanneke C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling

Blood (2012) 120 (21): 2677.

https://doi.org/10.1182/blood.V120.21.2677.2677

Published: 2012

NARROW

Hijacking of the Fibrinolytic System By B-Cell Acute Lymphoblastic Leukaemia and Its Therapeutic Targeting

Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies

The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13

Treatment of Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Subgroup Analysis of the Randomized German Hodgkin Study Group HD16 Study

LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

Identification of Posttranvslationally Modified Neoantigens As Targets of B Cell Receptors of Burkitt Lymphoma

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network

The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL

Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only